OptimizeRx Corp — Director's Dealing 2025

Nov 10, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2025-08-21

Reporting Person: Merrell Brendan W. (CHIEF OPERATING OFFICER)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	17274	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$15.04	2027-10-03	Common Stock (9764)		Direct
Stock Option	$12.73	2028-12-19	Common Stock (2946)		Direct
Stock Option	$4.94	2029-12-11	Common Stock (13723)		Direct
Stock Option	$16.14	2030-08-21	Common Stock (23437)		Direct

Footnotes

F1: Includes 10,900 shares of common stock underlying unvested restricted stock units ("RSUs") granted under OPRX's equity incentive plans. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of OPRX common stock. The RSUs vest as follows: (i) 1,663 RSUs which represent the 3rd installment of Mr. Merell's October 3, 2022 grant; (ii) 1,964 RSUs which represent the 2nd and 3rd installments of Mr. Merrell's December 19, 2023 grant; and (iii) 7,273 RSUs which will vest in 3 equal annual installments beginning on December 11, 2025, which is the 1st anniversary of the grant date.

F2: The stock option vests in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.

F3: The stock option vests in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.

F4: The stock option vests in three equal annual installments beginning December 11, 2025, the first anniversary of the grant date.

F5: The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.